[1] |
国家卫生计生委办公厅, 教育部办公厅. 关于印发学校结核病防控工作规范(2017版)的通知[EB/OL]. (2017-06-26)[2021-12-16]. http://www.moe.gov.cn/srcsite/A17/moe_943/s3285/201707/t20170727_310182.html.
|
[2] |
国家卫生健康委办公厅, 教育部办公厅. 关于印发中国学校结核病防控指南的通知[EB/OL].(2020-10-16)[2021/12/16]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=5f40b53827ae41c5ab7827507d584cab.
|
[3] |
国家卫生健康委, 教育部. 关于印发中小学生健康体检管理办法(2021年版)的通知[EB/OL]. (2021-09-30)[2021-12-16]. http://www.nhc.gov.cn/yzygj/s7659/202110/331a6dbacf24 4f7eac9dabcf758f387a.shtml.
|
[4] |
World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. Geneva: World Health Organization, 2020.
|
[5] |
Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev, 2014, 27(1):3-20. doi: 10.1128/CMR.00034-13.
doi: 10.1128/CMR.00034-13
URL
|
[6] |
Li H, Xin H, Qian S, et al. Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette-Guérin booster vaccination: subgroup analysis of a population-based cross-sectional study. Frontiers of Medicine, 2017, 11(4):528-535. doi: 10.1007/s11684-017-0573-0.
doi: 10.1007/s11684-017-0573-0
URL
|
[7] |
祁雪, 吴喜蓉, 郭雅洁, 等. 住院儿童结核分枝杆菌潜伏感染筛查情况分析. 中国防痨杂志, 2021, 43(7):653-658. doi: 10.3969/j.issn.1000-6621.2021.07.003.
doi: 10.3969/j.issn.1000-6621.2021.07.003
|
[8] |
祁雪, 王亚翠, 郭雅洁, 等. 两种检测技术在不同危险因素等级儿童中筛查潜伏性结核感染的结果分析. 中国防痨杂志, 2018, 40(9):924-931. doi: 10.3969/j.issn.1000-6621.2018.09.004.
doi: 10.3969/j.issn.1000-6621.2018.09.004
|
[9] |
卢鹏, 刘巧, 竺丽梅, 等. 中国东部地区结核菌素试验诊断结核病感染临界值的确定:基于人群的现况调查. 中华流行病学杂志, 2020, 41(3):363-364. doi: 10.3760/cma.j.issn.0254-6450.2020.03.016.
doi: 10.3760/cma.j.issn.0254-6450.2020.03.016
|
[10] |
高磊, 权竹声, 成君, 等. 结核分枝杆菌感染检测两步法在学校结核病控制工作中的应用探讨. 中华预防医学杂志, 2020, 54(4):385-391. doi: 10.3760/cma.j.cn112150-20191204-00909.
doi: 10.3760/cma.j.cn112150-20191204-00909
|
[11] |
Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA, 2005, 293(22):2756-2761. doi: 10.1001/jama.293.22.2756.
doi: 10.1001/jama.293.22.2756
URL
|
[12] |
Erkens CGM, Dinmohamed AG, Kamphorst M, et al. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands. Int J Tuberc Lung Dis, 2014, 18(4):413. doi: 10.5588/ijtld.13.0589.
doi: 10.5588/ijtld.13.0589
pmid: 24670695
|
[13] |
Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest, 2007, 131(5):1424-1434. doi: 10.1378/chest.06-2728.
doi: 10.1378/chest.06-2728
URL
|
[14] |
Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC pulmonary medicine, 2010, 10(1):7. doi: 10.1186/1471-2466-10-7.
doi: 10.1186/1471-2466-10-7
URL
|
[15] |
Nienhaus A, Schablon A, Costa JT, et al. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC health services research, 2011, 11(1):247. doi: 10.1186/1472-6963-11-247.
doi: 10.1186/1472-6963-11-247
URL
|
[16] |
Internal Clinical Guidelines Team (UK). Tuberculosis: Prevention, Diagnosis, Management and Service Organisatio. London:National Institute for Health and Care Excellence(UK), 2016.
|
[17] |
Haute Autorité De Santé. Tests in vitro de dépistage de l'infection tuberculeuse latente par détection de production d'interféron gamma. France:Saint-Denis La Plaine Cedex,2015.
|
[18] |
Schaberg T, Bauer T, Brinkmann F, et al. Tuberculosis Guideline for Adults-Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP). Pneumologie (Stuttgart, Germany), 2017, 71(6):325. doi: 10.1055/s-0043-105954.
doi: 10.1055/s-0043-105954
URL
|
[19] |
Swiss Lung Association. Handbuch Tuberkulose-revidierte Version January 2021. Bern: Swiss Lung Association,2021.
|
[20] |
Hpsc HPSC. National TB Advisory Committee. Guidelines on the prevention and control of tuberculosis in Ireland 2010. Dublin: Health Protection Surveillance Centre, 2009.
|
[21] |
Ministero Della Salute. Aggiornamento della Raccomandazioni per le attivita di controllo della tuberculosi nella poplazione immigrata. Roma: Ministero della Salute, 2010.
|